In summary, our results indicate that R-RAS2 overexpression is associated with increased activity of both the Raf-ERK and PI3K/Akt pathways as well as the mTORC1 pathway in freshly isolated breast tumors. This evidence concerns the gene AKT1 and breast neoplasm.